CCAAT/enhancer-binding protein β regulates the repression of type II collagen expression during the differentiation from proliferative to hypertrophic chondrocytes

Journal of Biological Chemistry

Volumn 289, Issue 5, 2014, Pages 2852-2863

  Ushijima, Takahiro ^a   Okazaki, Ken ^a   Tsushima, Hidetoshi ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C/EBP TRANSCRIPTION FACTOR; CHONDROCYTES; COLLAGEN; DIFFERENTIATION; OSTEOARTHRITIS;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHONDROCYTES; COLLAGEN TYPE II; COLLAGEN TYPE X; HYPERTROPHY; MICE; ORGAN CULTURE TECHNIQUES; RNA, SMALL INTERFERING; SOX9 TRANSCRIPTION FACTOR; TIBIA;

EID: 84893476437     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.492843     Document Type: Article

References (42)

1. Kronenberg, H. M. (2003) Developmental regulation of the growth plate. Nature 423, 332-336
2. Sandell, L. J., and Aigner, T. (2001) Articular cartilage and changes in arthritis. An introduction. Cell biology of osteoarthritis. Arthritis Res. 3, 107-113
3. Okazaki, K., and Sandell, L. J. (2004) Extracellular matrix gene regulation. Clin. Orthop. Relat. Res. 427, (suppl.) S123-S128
4. Shapiro, F. (2008) Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur. Cell Mater. 15, 53-76
5. Akiyama, H. (2008) Control of chondrogenesis by the transcription factor Sox9. Mod. Rheumatol. 18, 213-219
6. Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R., and De Crombrugghe, B. (1999) Sox9 is required for cartilage formation. Nat Genet. 22, 85-89
7. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N, and De Crombrugghe, B. (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro α1 (II) collagen gene. Mol. Cell Biol. 17, 2336-2346
8. Bell, D. M., Leung, K. K., Wheatley, S. C, Ng, L. J., Zhou, S., Ling, K. W., Sham, M. H., Koopman, P., Tam, P. P., and Cheah, K. S. (1997) SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16, 174-178
9. Hattori, T., Müller, C, Gebhard, S., Bauer, E., Pausch, F., Schlund, B., Bösl, M. R., Hess, A., Surmann-Schmitt, C, Von Der Mark, H, De Crombrugghe, B., and Von Der Mark, K. (2010) SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development. 137, 901-911
10. Yano, F., Kugimiya, F., Ohba, S., Ikeda, T., Chikuda, H., Ogasawara, T., Ogata, N, Takato, T., Nakamura, K., Kawaguchi, H., and Chung, U. I. (2005) The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem. Biophys. Res. Commun. 333, 1300-1308
11. Zehentner, B. K., Dony, C, and Burtscher, H. (1999) The transcription factor Sox9 is involved in BMP-2 signaling. J. Bone Miner. Res. 14, 1734-1741
12. Huang, W., Chung, U. I., Kronenberg, H. M., and De Crombrugghe, B. (2001) The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc. Natl. Acad. Sci. U. S. A. 98, 160-165
13. Murakami, S., Lefebvre, V., and De Crombrugghe, B. (2000) Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-α. J. Biol. Chem. 275, 3687-3692
14. Cheng, A., and Genever, P. G. (2010) SOX9 determines RUNX2 transactivity by directing intracellular degradation. J. Bone Miner. Res. 25, 2680-2689
15. Akira, S., Isshiki, H, Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906
16. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N, Fujiwara, H., Suematsu, S., Yoshida, N., and Kishimoto, T. (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361
17. Johnson, P. F. (2005) Molecular stop signs. Regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118, 2545-2555
18. Nerlov, C. (2007) The C/EBP family of transcription factors. A paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17, 318-324
19. Carro, M. S., Lim, W. K., Alvarez, M. J., Bollo, R. J., Zhao, X., Snyder, E. Y., Sulman, E. P., Anne, S. L., Doetsch, F., Colman, H, Lasorella, A., Aldape, K., Califano, A., and Iavarone, A. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325
20. Okazaki, K., Li, J., Yu, H., Fukui, N, and Sandell, L. J. (2002) CCAAT/enhancer-binding proteins β and S mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-10. J. Biol. Chem. 277, 31526-31533
21. Tsushima, H, Okazaki, K., Hayashida, M., Ushijima, T., and Iwamoto, Y. (2012) CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis. Ann. Rheum. Dis. 71, 99-107
22. Hayashida, M., Okazaki, K., Fukushi, J., Sakamoto, A., and Iwamoto, Y. (2009) CCAAT/enhancer binding protein β mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis. Arthritis Rheum. 60, 708-716
23. Hirata, M., Kugimiya, F., Fukai, A., Ohba, S., Kawamura, N, Ogasawara, T., Kawasaki, Y., Saito, T., Yano, F., Ikeda, T., Nakamura, K., Chung, U. I., and Kawaguchi, H. (2009) C/EBPβ Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS One 4, e4543
24. Hirata, M., Kugimiya, F., Fukai, A., Saito, T., Yano, F., Ikeda, T., Mabuchi, A., Sapkota, B. R., Akune, T., Nishida, N, Yoshimura, N, Nakagawa, T., Tokunaga, K., Nakamura, K., Chung, U. I., and Kawaguchi, H. (2012) C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2α as the inducer in chondrocytes. Hum. Mol. Genet. 21, 1111-1123
25. Lefebvre, V., Garofalo, S., Zhou, G., Metsäranta, M., Vuorio, E., and De Crombrugghe, B. (1994) Characterization of primary cultures of chondrocytes from type II collagen/β-galactosidase transgenic mice. Matrix Biol. 14, 329-335
26. Sakaue, H., Konishi, M., Ogawa, W., Asaki, T., Mori, T., Yamasaki, M., Takata, M., Ueno, H, Kato, S., Kasuga, M., and Itoh, N. (2002) Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev. 16, 908-912
27. Descombes, P., and Schibler, U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569-579
28. Olive, M., Williams, S. C, Dezan, C, Johnson, P. F., and Vinson, C (1996) Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties. J. Biol. Chem. 271, 2040-2047
29. Haaijman, A., D'Souza, R. N, Bronckers, A. L., Goei, S. W., and Burger, E. H. (1997) OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro. J. Bone Miner. Res. 12, 1815-1823
30. Komori, T. (2010) Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 339, 189-195
31. Shukunami, C, Shigeno, C, Atsumi, T., Ishizeki, K., Suzuki, F., and Hiraki, Y. (1996) Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro. Differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol. 133, 457-468
32. Akiyama, H., Kamitani, T., Yang, X., Kandyil, R., Bridgewater, L. C, Fellous, M., Mori-Akiyama, Y., and De Crombrugghe, B. (2005) The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biol. 23, 499-505
33. Sekiya, I., Tsuji, K., Koopman, P., Watanabe, H, Yamada, Y., Shinomiya, K., Nifuji, A., and Noda, M. (2000) SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilagederived cell line, TC6. J. Biol. Chem. 275, 10738-10744
34. Furumatsu, T., Tsuda, M., Yoshida, K., Taniguchi, N, Ito, T., Hashimoto, M., Ito, T., and Asahara, H. (2005) Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J. Biol. Chem. 280, 35203-35208
35. Imamura, T., Imamura, C, Iwamoto, Y., and Sandell, L. J. (2005) Transcriptional Co-activators CREB-binding protein/p300 increase chondrocyte Cd-rap gene expression by multiple mechanisms including sequestration of the repressor CCAAT/enhancer-binding protein. J. Biol. Chem. 280, 16625-16634
36. Goldring, M. B., Birkhead, J. R., Suen, L. F., Yamin, R., Mizuno, S., Glowacki, J., Arbiser, J. L., and Apperley, J. F. (1994) Interleukin-1β- modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94, 2307-2316
37. Tan, L., Peng, H., Osaki, M., Choy, B. K., Auron, P. E., Sandell, L. J., and Goldring, M. B. (2003) Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1β. J. Biol. Chem. 278, 17688-17700
38. Peng, H., Tan, L., Osaki, M., Zhan, Y., Ijiri, K., Tsuchimochi, K., Otero, M., Wang, H., Choy, B. K., Grall, F. T., Gu, X., Libermann, T. A., Oettgen, P., and Goldring, M. B. (2008) ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J. Cell Physiol. 215, 562-573
39. Higashikawa, A., Saito, T., Ikeda, T., Kamekura, S., Kawamura, N., Kan, A., Oshima, Y., Ohba, S., Ogata, N, Takeshita, K., Nakamura, K., Chung, U. I., and Kawaguchi, H. (2009) Identification of the core element responsive to runt-related transcription factor 2 in the promoter of human type X collagen gene. Arthritis Rheum. 60, 166-178
40. Tominaga, H., Maeda, S., Hayashi, M., Takeda, S., Akira, S., Komiya, S., Nakamura, T., Akiyama, H., and Imamura, T. (2008) CCAAT/enhancerbinding protein β promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol. Biol. Cell 19, 5373-5386
41. Kamekura, S., Kawasaki, Y., Hoshi, K., Shimoaka, T., Chikuda, H., Maruyama, Z., Komori, T., Sato, S., Takeda, S., Karsenty, G., Nakamura, K., Chung, U. I., and Kawaguchi, H. (2006) Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54, 2462-2470
42. Benito, M. J., Veale, D. J., Fitz Gerald, O., Van Den Berg, W. B., and Bresnihan, B. (2005) Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64, 1263-1267